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Every year, Iowa welcomes an average of 38,000 
newborns. On the basis of known rates of drug use, 
we would expect 7-8 percent, or about 2800 infants, to 
have been exposed to drugs in utero. With an appro-
priate screening program, health care providers would 
identify about 1,200 of these newborns, and then refer 
them for evaluation and services. 
In Iowa in 2004, however, as a result of inadequate 
screening and testing, only 549 newborns were con-
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firmed as having been exposed to drugs in utero. In-
fants who have been exposed to drugs but who remain 
unidentified will be discharged to homes in which 
mothers are likely to continue to use drugs. Often these 
infants face continuing exposure to drugs and to the 
chaotic lifestyle and lack of nurturing so often associ-
ated with drug use.
Some states, such as California and Virginia, have man-
dated maternal and neonatal drug screening protocols 
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Iowa Alliance for Drug Endangered Children (DEC), www.
iowadec.net/; and DEC response guidelines for law enforce-
ment officials, …uploads/Law%20Enforcement%20Proto-
col%20-20Card%20ALL%20(2).pdf
Methamphetamine abuse in Iowa, A report to the legislature, 
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for hospitals. Other states, such as Arizona, Washington, 
and Indiana, have developed a statewide consensus on 
perinatal screening for drugs, and established education 
programs in all birthing hospitals. In addition to state-
wide efforts, many individual hospitals, often in urban 
areas, have developed structured screening and testing 
protocols. State, community, and individual hospital ef-
forts have continued to grow in response to our increas-
ing awareness of the extent of perinatal drug exposure. 
In Iowa, health care professionals have long recog-
nized the need for programs to identify perinatal drug 
exposure. Some Iowa hospitals have developed and im-
plemented protocols to guide medical staff in screening 
mothers and newborns for specific high-risk factors. 
Parallel to this, Iowa code encourages health profes-
sionals to perform perinatal screening and testing for 
drugs when risk factors are recognized and documented. 
However, Iowa code leaves the specific definition of these 
risk factors to the discretion of the clinician. In addition, 
Iowa has not mandated that birthing hospitals develop 
screening and testing protocols. As a result, tremendous 
variation exists among Iowa birthing hospitals regard-
ing perinatal drug screening. Most community hospitals 
do no screening at all. Some do randomized screening, 
such as testing every 15th or 20th infant. Often, whether 
a mother is screened, tested, or exempted depends on the 
personal perceptions (and biases) of the medical staff. 
A study conducted in Iowa birthing hospitals found 
that hospitals using a structured screening or testing pro-
tocol test twice as many infants as hospitals that have no 
protocol. At hospitals that use a screening protocol, the 
rate of positive test results – infants identified as having 
been exposed to in utero drug exposure -- is almost five 
times higher than in hospitals without such a protocol. 
But less than half of the infants born in Iowa are delivered 
in hospitals that use a structured protocol for screening 
and testing. 
However, even hospitals that use protocols often pro-
vide no specific training, which reduces the effectiveness 
of screening and testing. In one urban hospital in Iowa, 
and despite the availability of a structured protocol, al-
most one-third of eligible infants were not screened be-
cause staff did not follow the protocol. 
As a result of growing concern about perinatal drug 
exposure, a statewide collaboration came together to 
develop a targeted, risk-based perinatal drug screening, 
testing, and intervention protocol to be adopted by every 
birthing hospital in Iowa. Participants in this collabora-
tion include:
•  Iowa Department of Public Health
•  Iowa Hospital Association
•  American Academy of Pediatrics, Iowa Chapter
•  Drug Endangered Children Alliance of Iowa
•  Iowa Child Protection Council
•  Iowa Child Protection Centers and programs, includ-
ing the University of Iowa Children’s Hospital in Iowa 
City, Blank Children’s Hospital in Des Moines, St. 
Luke’s Hospital in Cedar Rapids, Mercy Hospital in 
Sioux City, and Davenport Child Abuse Task Force. 
The Perinatal Care Program Advisory Council of the 
Iowa Department of Public Health has approved a screen-
ing protocol (see “Perinatal Illicit Drug Exposure Risk As-
sessment Tool,” page 62), and this is now included in the 
Guidelines for Perinatal Services, 8th edition, 2008. The 
Statewide Perinatal Care Team is currently disseminat-
ing this protocol to birthing hospitals around the state. It 
calls for screening for perinatal drug exposure to be per-
formed in the prenatal clinic, labor and delivery unit, and 
newborn nursery unit or NICU. An electronic version 
of the Guidelines for Perinatal Services can be found at: 
www.idph.state.ia.us/hpcdp/statewide_perinatal_care.asp
Prenatal clinics play a key role in identifying perina-
tal drug use, and in offering the mother the opportunity 
for testing and intervention. Prenatal clinic staff should 
screen mothers when they first visit the prenatal clinic. If 
the initial screening is negative, staff should verify absti-
nence from illicit drug use at every subsequent visit.  
Mothers who are reluctant to abstain from drug use 
may not be willing to disclose addiction, and may refuse 
to give consent for testing and intervention. When that 
happens, hospitals need to have a system in place to in-
sure that information about this at-risk mother and child 
is communicated from the prenatal clinic to the labor and 
delivery unit and to the newborn nursery or NIC. 
Implementing a standard protocol allows health care 
providers to identify most drug exposed newborns and 
provide or refer for treatment. Such a protocol also allows 
providers to link the mother to the services she needs to 
become the parent she wants and deserves to be.
 —Resmiye Oral, MD
 Clinical Associate Professor of Pediatrics
 Director, Child Protection Program
 University of Iowa Hospitals and Clinics
 http://www.uihealthcare.com/childprotection/
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